Tilray to Build $24 Million Medical Cannabis Cultivation and Processing Facility in Portugal

Tilray, a federally licensed cannabis producer based in British Columbia, recently announced plans to build a €20 million ($24 million) European campus in Portugal to cultivate, process, package, and distribute GMP-grade medical cannabis products to qualified patients, pharmacies, and researchers throughout the European common market. “Tilray’s EU campus is another strategic milestone as we aim to build the world’s most trusted and admired medical cannabis brand,” said Brendan Kennedy, Chief Executive Officer of Tilray.   The 270,000 square foot campus will be located in the BIOCANT Research Park in Cantanhede, Portugal and will be constructed in phases over the...

Read More